Skip to content

Remoxipride

NERVOUS SYSTEM

Also known as: (S)-Remoxipride, remoxipride HCl, remoxipride hydrochloride

YEAR INTRODUCED approvedATC N05AL04

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Remoxipride is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1990. DrugCentral lists 10 molecular targets, including SIGMAR1, DRD3 and DRD2.

  • Molecular targets: SIGMAR1, DRD3, DRD2 and DRD2 (10 listed in DrugCentral).
  • ATC code: N05AL04 (Benzamides).
  • Molecular formula: C16H23BrN2O3; molecular weight 371.27 g/mol.

Mechanism & targets

Molecular targets (10)

TargetGeneActionActivity
Sigma non-opioid intracellular receptor 1SIGMAR1unknownKi 7.26
D(3) dopamine receptorDRD3unknownKi 7.16
D(2) dopamine receptorDRD2unknownKi 6.06
D(2) dopamine receptorDRD2antagonistIC50 6.06
D(2) dopamine receptorDrd2unknownIC50 5.85
Dopamine receptorDrd1|Drd3|Drd5|Drd4|Drd2unknownIC50 5.80
5-hydroxytryptamine receptor 2AHTR2AunknownKi 5.51
D(4) dopamine receptorDRD4unknownKi 5.41
5-hydroxytryptamine receptor 1AHTR1AunknownKd 5.40
D(3) dopamine receptorDRD3unknownKi 5.34

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1990-01-01YEAR INTRODUCED——

ATC classification

ATC codeTherapeutic hierarchy
N05AL04NERVOUS SYSTEM › PSYCHOLEPTICS › ANTIPSYCHOTICS › Benzamides

Chemical structure

Molecular formulaC16H23BrN2O3
Molecular weight371.27 g/mol
CAS number80125-14-0
InChIKeyGUJRSXAPGDDABA-NSHDSACASA-N
PubChem CID54477
CCN1CCC[C@H]1CNC(=O)C1=C(OC)C(Br)=CC=C1OC

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Remoxipride work?

Its molecular targets in DrugCentral include SIGMAR1, DRD3, DRD2 and DRD2 (antagonist).

When was Remoxipride first approved?

Remoxipride was first approved by the YEAR INTRODUCED in 1990.

What is the chemical formula of Remoxipride?

Remoxipride has the molecular formula C16H23BrN2O3 and a molecular weight of 371.27 g/mol.

Browse: all drugs starting with R · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval1990-01-01
AgencyYEAR INTRODUCED
Targets10
Indications0
FormulaC16H23BrN2O3
DrugCentral ID2365
Interactive profile